Biognosys

Biognosys company information, Employees & Contact Information

Explore related pages

Related company profiles:

The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making. Our Solutions We offer a versatile portfolio of proprietary proteomics services, software, and kits. We make these widely available for pharmaceutical and biotechnology researchers and proteomics experts. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all major sample types – cells, tissues, or body fluids – across human and non-human species. Our Technology Biognosys is the leading inventor and developer of mass spectrometry-based proteomics solutions. With market leading proteome coverage and sample throughput we enable simultaneous quantification of thousands of proteins across thousands of samples. Our Facility Biognosys’ high-end mass spectrometry facilities in Switzerland and the US provide world-leading capacity for proteomics contract research. From our two facilities, we make a broad spectrum of discovery, targeted, and structural proteomics solutions globally accessible. Our Data Competence Biognosys has analyzed a vast amount of proteomics data and developed an industry-leading understanding of the proteome. Through advanced data analytics, Biognosys translates data into actionable insights for R&D and clinical research. Global Presence Founded in 2008 as a spin-off from the lab of proteomics pioneer Ruedi Aebersold at ETH Zurich, Biognosys today is an established leader in next-generation proteomics. With employees based across Switzerland, Europe, and US, and an extensive network of collaborators and distributors, Biognosys supports a global customer base of life science researchers across industry and academia.
Looking for a particular Biognosys employee's phone or email?

Biognosys Questions

News

A Flexible End-to-End Automated Sample Preparation Workflow Enables Standardized and Scalable Bottom-up Proteomics - ACS Publications

A Flexible End-to-End Automated Sample Preparation Workflow Enables Standardized and Scalable Bottom-up Proteomics ACS Publications

Bruker buys major interest in Biognosys to boost CRO biz - BioXconomy

Bruker buys major interest in Biognosys to boost CRO biz BioXconomy

A Flexible End-to-End Automated Sample Preparation Workflow Enables Standardized and Scalable Bottom-up Proteomics | Analytical Chemistry - ACS Publications

A Flexible End-to-End Automated Sample Preparation Workflow Enables Standardized and Scalable Bottom-up Proteomics | Analytical Chemistry ACS Publications

Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers - Yahoo Finance

Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers Yahoo Finance

Biognosys Enters Reselling Agreement for Spectronaut - GlobeNewswire

Biognosys Enters Reselling Agreement for Spectronaut GlobeNewswire

Expanding the Drug Target Universe: How Next-Generation Proteomics Is Transforming Oncology Research - Technology Networks

Expanding the Drug Target Universe: How Next-Generation Proteomics Is Transforming Oncology Research Technology Networks

Biognosys Announces New Release of Spectronaut™ - Business Wire

Biognosys Announces New Release of Spectronaut™ Business Wire

Biognosys’ Proteomics CRO Facility, Massachusetts, US - Pharmaceutical Technology

Biognosys’ Proteomics CRO Facility, Massachusetts, US Pharmaceutical Technology

Biognosys Inc - Massachusetts Biotechnology Council

Biognosys Inc Massachusetts Biotechnology Council

Bruker expands CRO business with Biognosys majority ownership deal - Fierce Biotech

Bruker expands CRO business with Biognosys majority ownership deal Fierce Biotech

Combining Precursor and Fragment Information for Improved Detection of Differential Abundance in Data Independent Acquisition - ScienceDirect.com

Combining Precursor and Fragment Information for Improved Detection of Differential Abundance in Data Independent Acquisition ScienceDirect.com

Biognosys Launches Spectronaut 18 and Presents Advances in - GlobeNewswire

Biognosys Launches Spectronaut 18 and Presents Advances in GlobeNewswire

Europe Proteomics Research Report 2025: Market Insights, Competitive Landscape and Forecasts 2024-2034 Featuring Biognosys, DiaSorin, Merck, Oxford Expression Technologies - Yahoo Finance

Europe Proteomics Research Report 2025: Market Insights, Competitive Landscape and Forecasts 2024-2034 Featuring Biognosys, DiaSorin, Merck, Oxford Expression Technologies Yahoo Finance

Using Protein Biomarkers Increases the Chances of Success in Clinical Trials - Technology Networks

Using Protein Biomarkers Increases the Chances of Success in Clinical Trials Technology Networks

Biognosys Launches Spectronaut 19 and Presents Advances - GlobeNewswire

Biognosys Launches Spectronaut 19 and Presents Advances GlobeNewswire

Biomarker Candidates for Tumors Identified from Deep-Profiled Plasma Stem Predominantly from the Low Abundant Area - ACS Publications

Biomarker Candidates for Tumors Identified from Deep-Profiled Plasma Stem Predominantly from the Low Abundant Area ACS Publications

Proteomics Is Ready for Primetime - Technology Networks

Proteomics Is Ready for Primetime Technology Networks

Biognosys launches groundbreaking P2 Plasma Enrichment - GlobeNewswire

Biognosys launches groundbreaking P2 Plasma Enrichment GlobeNewswire

Mechanistic Insights into a CDK9 Inhibitor Via Orthogonal Proteomics Methods - ACS Publications

Mechanistic Insights into a CDK9 Inhibitor Via Orthogonal Proteomics Methods ACS Publications

Analysis of 1508 Plasma Samples by Capillary-Flow Data-Independent Acquisition Profiles Proteomics of Weight Loss and Maintenance - ScienceDirect.com

Analysis of 1508 Plasma Samples by Capillary-Flow Data-Independent Acquisition Profiles Proteomics of Weight Loss and Maintenance ScienceDirect.com

Comparison of Protein Quantification in a Complex Background by DIA and TMT Workflows with Fixed Instrument Time - ACS Publications

Comparison of Protein Quantification in a Complex Background by DIA and TMT Workflows with Fixed Instrument Time ACS Publications

Protocol for quantitative proteomic analysis of heterogeneous adipose tissue-residing progenitor subpopulations in mice - ScienceDirect.com

Protocol for quantitative proteomic analysis of heterogeneous adipose tissue-residing progenitor subpopulations in mice ScienceDirect.com

Biognosys Launches Spectronaut 16 and Presents Major Advances to its Proteomics Platforms at the ASMS 2022 Annual Conference - STT Info

Biognosys Launches Spectronaut 16 and Presents Major Advances to its Proteomics Platforms at the ASMS 2022 Annual Conference STT Info

Biognosys Expands Co-Marketing Agreement with Global Life Science Leader to Advance Proteomics - Via TT

Biognosys Expands Co-Marketing Agreement with Global Life Science Leader to Advance Proteomics Via TT

Biognosys Brings Proteomic Breakthroughs to Mainstream Users - Pressetext

Biognosys Brings Proteomic Breakthroughs to Mainstream Users Pressetext

Top Biognosys Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant